Last reviewed · How we verify
NVN1000 1% Gel
At a glance
| Generic name | NVN1000 1% Gel |
|---|---|
| Also known as | NVN1000 |
| Sponsor | Novan, Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne (PHASE3)
- Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy Volunteers (PHASE1)
- A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers (PHASE1)
- SB208 for the Treatment of Tinea Pedis (PHASE2)
- A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne (PHASE2)
- A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 Gel (PHASE1)
- Study of NVN1000 Topical Gel and Topical Gel Vehicle in the Treatment of Moderate to Severe Acne Vulgaris (PHASE1, PHASE2)
- A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |